Northwest Biotherapeutics, Inc. ( NWBO) - Key Metrics
NWBO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.01 | $0 | $0 |
| 2026Q1 | $0 | $0 | -$0.01 | -$0.01 |
| 2025Q4 | $0 | $0 | -$0.01 | -$0.01 |
| 2025Q3 | $0 | -$0.02 | -$0.01 | -$0.01 |
| 2025Q2 | $0 | -$0.01 | $0 | $0 |
NWBO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.67 |
| 2026Q1 | 0% | -24.58 |
| 2025Q4 | 0% | 63.19 |
| 2025Q3 | 0% | -3.30 |
| 2025Q2 | 0% | -5.30 |
NWBO
Price: $0.19
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
P/E Ratio: -3.73
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.3 million
Ebitda: -69.1 millionMarket Capitalization: 261.3 million